… how well real-world patients with a broad spectrum of creatinine clearance would achieve
target plasma dabigatran trough concentrations associated with efficacy and safety. However, …

… Postmarketing safety studies and pragmatic clinical trials as … to assess the effectiveness
and safety of dabigatran etexi- … the safety and effectiveness of dabigatran etexilate in real-life …

… in patients administered dabigatran during hospitalization and documents how real-life
prescribing practices align with dosing recommendations made by dabigatran manufacturers to …

… adherence to dabigatran and even to its discontinuation [[13], [14], [15], [16]]. … of dabigatran
induced GI discomfort (DGID) and its impact on the adherence and persistence of dabigatran …

… evaluate the safety and efficacy of dual antithrombotic therapy with dabigatran versus triple
… from 10 high-quality real-world studies to estimate the MI risk of dabigatran. In our study, the …

… We examined the effects of dabigatran 110 mg twice daily, dabigatran 150 mg twice daily
and warfarin on the risk of outcome events in the age subgroups (<75, 75 to <80, 80 to <85 and …

… the use of dabigatran among patients with … safety of dabigatran bid globally and stratified
by dose (110 or 150 mg bid), compared to VKA in non-Asian patients with NVAF from “real-world…

… The safety of the novel oral anticoagulant dabigatran has … safety and efficacy of dabigatran.
In this study, we aimed to compare the safety profile of the novel oral anticoagulant dabigatran…

… -life the peak and trough dabigatran plasma concentrations over time in a very old geriatric
population, to identify the determinants of dabigatran … between dabigatran concentration and …

… is high in our dabigatran population but the majority seems to … of dabigatran is crucial for the
effect in view of the half-life of 12… the daily routines of the patient and would not reflect a real-…